
A case report of coronavirus disease‐2019‐induced acute asthma exacerbation in an obese patient
Author(s) -
Sasaki Hisashi,
Miyata Jun,
Kobayashi Ai,
Kawano Shuichi,
Kawana Akihiko
Publication year - 2022
Publication title -
respirology case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.304
H-Index - 9
ISSN - 2051-3380
DOI - 10.1002/rcr2.979
Subject(s) - medicine , exacerbation , asthma , asthma exacerbations , covid-19 , coronavirus , pandemic , disease , intensive care medicine , virology , infectious disease (medical specialty) , outbreak
The coronavirus disease‐2019 ( COVID ‐19) has spread worldwide. Previous studies indicated a low prevalence of COVID ‐19 induced acute exacerbations of asthma. We present a 39‐year‐old‐male obese asthmatic case who experienced acute asthma exacerbation during COVID ‐19. On day 8 of infection, his cough and dyspnea worsened with hypoxia and wheezing. Laboratory test results revealed elevated interleukin‐6 ( IL ‐6) and total immunoglobulin E ( IgE ) levels without eosinophilia. Two months since the onset, hypoxia disappeared with decreased IL ‐6 and IgE levels. Our case suggested that obesity and high serum IL ‐6 and IgE levels may have contributed to atypical asthma exacerbation in COVID ‐19.